Published in Viruses on October 12, 2012
Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus. J Virol (2014) 0.79
Evidence of human infection by a new mammarenavirus endemic to Southeastern Asia. Elife (2016) 0.76
Analyses of Entry Mechanisms of Novel Emerging Viruses Using Pseudotype VSV System. Trop Med Health (2014) 0.75
Serologic assays for the detection and strain identification of Pteropine orthoreovirus. Emerg Microbes Infect (2016) 0.75
A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med (2008) 7.73
Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J Gen Virol (1987) 6.41
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96
Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog (2009) 4.88
ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92
Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A (1996) 3.54
Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis (2007) 3.51
Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg (1972) 3.44
Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology (1981) 3.26
Laboratory diagnosis of Nipah and Hendra virus infections. Microbes Infect (2001) 3.08
Lassa fever. Curr Top Microbiol Immunol (2002) 3.01
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69
Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 2.61
Human infection with arenaviruses in the Americas. Curr Top Microbiol Immunol (2002) 2.32
Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog (2008) 2.23
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. Viral Immunol (2008) 2.11
High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J Virol (1997) 2.07
Lassa fever: epidemiology, clinical features, and social consequences. BMJ (2003) 2.06
Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J Gen Virol (1989) 1.92
Diagnosis of tick-borne encephalitis. Vaccine (2003) 1.90
Arenaviruses other than Lassa virus. Antiviral Res (2003) 1.86
Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ (1975) 1.86
Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res (2003) 1.82
Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch Pathol Lab Med (1992) 1.71
Historical Lassa fever reports and 30-year clinical update. Emerg Infect Dis (2006) 1.67
Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol (2000) 1.63
Mammalian reservoirs of arenaviruses. Curr Top Microbiol Immunol (2002) 1.62
Reston Ebolavirus antibodies in bats, the Philippines. Emerg Infect Dis (2011) 1.54
Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am J Obstet Gynecol (2002) 1.50
Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses. Proc Natl Acad Sci U S A (2008) 1.47
Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA. J Clin Microbiol (2010) 1.45
High seroprevalence of Rift Valley FEVER AND EVIDENCE FOR ENDEMIC circulation in Mbeya region, Tanzania, in a cross-sectional study. PLoS Negl Trop Dis (2012) 1.44
Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen. J Med Virol (1993) 1.43
Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J Clin Microbiol (2001) 1.39
Protective efficacy of neutralizing antibodies against Ebola virus infection. Vaccine (2006) 1.38
Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. J Virol (2004) 1.36
Arenaviruses: genomic RNAs, transcription, and replication. Curr Top Microbiol Immunol (2002) 1.35
Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J Gen Virol (1991) 1.35
Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J Clin Microbiol (2002) 1.35
Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or Cytomegalovirus infection. Pediatrics (1997) 1.34
Novel arenavirus sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d'Ivoire: implications for evolution of arenaviruses in Africa. PLoS One (2011) 1.32
Surveillance of Lassa fever in missionaries stationed in West Africa. Bull World Health Organ (1975) 1.27
Serological evidence of Crimean-Congo haemorrhagic fever viral infection among camels imported into Egypt. J Trop Med Hyg (1990) 1.26
Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. J Virol Methods (2006) 1.24
Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use. J Clin Microbiol (1998) 1.24
Genetic identification of Kodoko virus, a novel arenavirus of the African pigmy mouse (Mus Nannomys minutoides) in West Africa. Virology (2007) 1.22
An imported case of Lassa fever with late appearance of polyserositis. J Infect Dis (1988) 1.21
Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression. Biochem Biophys Res Commun (2004) 1.20
Catarina virus, an arenaviral species principally associated with Neotoma micropus (southern plains woodrat) in Texas. Am J Trop Med Hyg (2007) 1.19
Arenaviruses. Intervirology (1974) 1.18
Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J Virol (2008) 1.16
Current molecular epidemiology of Lassa virus in Nigeria. J Clin Microbiol (2010) 1.15
Identification of a small-molecule entry inhibitor for filoviruses. J Virol (2011) 1.14
A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses. Vaccine (2009) 1.11
Antigen-capture enzyme-linked immunosorbent assay for detection and quantification of Crimean-Congo hemorrhagic fever virus in the tick, Hyalomma truncatum. J Virol Methods (1993) 1.11
Mopeia virus-related arenavirus in natal multimammate mice, Morogoro, Tanzania. Emerg Infect Dis (2009) 1.11
Zoonotic aspects of arenavirus infections. Vet Microbiol (2009) 1.10
Diversity among Tacaribe serocomplex viruses (family Arenaviridae) naturally associated with the Mexican woodrat (Neotoma mexicana). Virus Res (2008) 1.10
Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol (2005) 1.09
Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin Diagn Lab Immunol (2003) 1.09
Novel arenavirus, Zambia. Emerg Infect Dis (2011) 1.06
Lassa fever: the first confirmed case imported into Canada. Can Dis Wkly Rep (1989) 1.05
Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology (2007) 1.05
Diversity among tacaribe serocomplex viruses (family Arenaviridae) naturally associated with the white-throated woodrat (Neotoma albigula) in the southwestern United States. Vector Borne Zoonotic Dis (2008) 1.05
A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells. Mol Pharmacol (2010) 1.03
Neutralizing antibody response to hepatitis C virus. Viruses (2011) 1.03
Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia. Trans R Soc Trop Med Hyg (1984) 1.03
A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa. Trop Doct (2006) 1.02
Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin. J Med Virol (1983) 1.01
Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene. J Virol Methods (2010) 1.01
Development of an immunofluorescence method for the detection of antibodies to Ebola virus subtype Reston by the use of recombinant nucleoprotein-expressing HeLa cells. Microbiol Immunol (2002) 1.00
Strain-specific antibody response to Lassa virus in the local population of west Africa. J Clin Virol (2007) 0.99
Different potential of C-type lectin-mediated entry between Marburg virus strains. J Virol (2010) 0.98
Development of an antigen-capture ELISA for detection of H7 subtype avian influenza from experimentally infected chickens. J Virol Methods (2007) 0.97
Genomic and phylogenetic characterization of Merino Walk virus, a novel arenavirus isolated in South Africa. J Gen Virol (2010) 0.97
Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus. Am J Trop Med Hyg (2006) 0.95
Immunofluorescence method for detection of Ebola virus immunoglobulin g, using HeLa cells which express recombinant nucleoprotein. J Clin Microbiol (2001) 0.95
Junin virus activity in rodents from endemic and nonendemic loci in central Argentina. Am J Trop Med Hyg (1991) 0.94
Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques. Intervirology (1992) 0.94
Complex patterns of host switching in New World arenaviruses. Mol Ecol (2012) 0.92
Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein. Clin Diagn Lab Immunol (2003) 0.92
Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever. Clin Vaccine Immunol (2007) 0.91
Antigen-capture ELISA for the detection of Rift Valley fever virus nucleoprotein using new monoclonal antibodies. J Virol Methods (2012) 0.91
A seroepidemiologic study of Reston ebolavirus in swine in the Philippines. BMC Vet Res (2012) 0.90
Characterization of monoclonal antibodies to Junin virus nucleocapsid protein and application to the diagnosis of hemorrhagic fever caused by South American arenaviruses. Clin Vaccine Immunol (2009) 0.89
Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa. J Clin Virol (2006) 0.87
Antigen-capture enzyme-linked immunosorbent assay for the diagnosis of crimean-congo hemorrhagic fever using a novel monoclonal antibody. J Med Virol (2005) 0.86
Standardization of a plaque assay for Lassa virus. J Med Virol (1987) 0.84
Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV. J Med Virol (2006) 0.84
Epidemiological survey of Crimean-Congo hemorrhagic fever virus in Yunnan, China, 2008. Int J Infect Dis (2011) 0.84
Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus. Virus Res (1991) 0.83
Recombinant nucleoprotein-based serological diagnosis of Crimean-Congo hemorrhagic fever virus infections. J Med Virol (2005) 0.81
Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase. J Virol Methods (2011) 0.81
Viral hemorrhagic fevers of South America. Biomedica (2002) 0.80
Argentine hemorrhagic fever diagnostic test based on recombinant Junín virus N protein. J Med Virol (2008) 0.80
Amino acid substitutions in the s2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells. J Virol (2007) 0.79
The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan. J Infect Dis (2013) 4.92
The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol (2005) 2.13
Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer (2004) 2.04
Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95. J Cell Biol (2009) 1.91
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci U S A (2005) 1.85
Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol (2008) 1.65
Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies. Clin Vaccine Immunol (2010) 1.59
Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLoS One (2012) 1.54
Reston Ebolavirus antibodies in bats, the Philippines. Emerg Infect Dis (2011) 1.54
Species-independent detection of RNA virus by representational difference analysis using non-ribosomal hexanucleotides for reverse transcription. Nucleic Acids Res (2005) 1.51
Animal models for Ebola and Marburg virus infections. Front Microbiol (2013) 1.51
Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults. J Infect Dis (2011) 1.48
Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J Immunol (2002) 1.42
LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox. J Virol (2006) 1.38
Immunofluorescence technique using HeLa cells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J Clin Microbiol (2002) 1.37
An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection. J Virol (2005) 1.37
Novel DNA virus isolated from samples showing endothelial cell necrosis in the Japanese eel, Anguilla japonica. Virology (2011) 1.37
Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J Clin Microbiol (2002) 1.35
Bat coronaviruses and experimental infection of bats, the Philippines. Emerg Infect Dis (2010) 1.32
Rapid determination of viral RNA sequences in mosquitoes collected in the field. J Virol Methods (2007) 1.27
Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol (2006) 1.26
Isolation of novel adenovirus from fruit bat (Pteropus dasymallus yayeyamae). Emerg Infect Dis (2008) 1.26
Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus. J Med Virol (2004) 1.23
Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia. Vaccine (2003) 1.23
Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J Virol (2008) 1.16
Rapid genome sequencing of RNA viruses. Emerg Infect Dis (2007) 1.15
Lethal canine distemper virus outbreak in cynomolgus monkeys in Japan in 2008. J Virol (2012) 1.14
Association of the nucleocapsid protein of the Seoul and Hantaan hantaviruses with small ubiquitin-like modifier-1-related molecules. Virus Res (2003) 1.13
Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Am J Pathol (2008) 1.12
Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein. J Virol (2006) 1.11
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. Int Immunol (2004) 1.10
Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8. JAMA (2009) 1.10
Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol (2005) 1.09
Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. Virology (2002) 1.08
Detection of bat coronaviruses from Miniopterus fuliginosus in Japan. Virus Genes (2011) 1.08
Divergent ancestral lineages of newfound hantaviruses harbored by phylogenetically related crocidurine shrew species in Korea. Virology (2012) 1.08
Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner. J Virol (2009) 1.05
Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston). Comp Immunol Microbiol Infect Dis (2007) 1.02
The intracellular association of the nucleocapsid protein (NP) of hantaan virus (HTNV) with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9). Virology (2003) 1.02
Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene. J Virol Methods (2010) 1.01
Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells. Biochem Biophys Res Commun (2004) 1.01
Novel betaherpesvirus in bats. Emerg Infect Dis (2010) 1.01
Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol (2006) 1.01
Development of an immunofluorescence method for the detection of antibodies to Ebola virus subtype Reston by the use of recombinant nucleoprotein-expressing HeLa cells. Microbiol Immunol (2002) 1.00
Recent progress in molecular biology of Crimean-Congo hemorrhagic fever. Comp Immunol Microbiol Infect Dis (2007) 1.00
The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine. J Virol (2012) 0.99
Ligation-mediated amplification for effective rapid determination of viral RNA sequences (RDV). J Clin Virol (2008) 0.98
Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 A. Virology (2008) 0.97
Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells. Virology (2004) 0.97
Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates. J Gen Virol (2009) 0.96
Progressive multifocal leukoencephalopathy developed in incomplete Heerfordt syndrome, a rare manifestation of sarcoidosis, without steroid therapy responding to cidofovir. Clin Neurol Neurosurg (2009) 0.96
Novel bat-borne hantavirus, Vietnam. Emerg Infect Dis (2013) 0.95
Inhibitory effect of quercetin on carrageenan-induced inflammation in rats. Life Sci (2003) 0.95
Baculovirus GP64-mediated entry into mammalian cells. J Virol (2011) 0.95
Analysis of linear B-cell epitopes of the nucleoprotein of ebola virus that distinguish ebola virus subtypes. Clin Diagn Lab Immunol (2003) 0.94
Two autopsy cases of severe fever with thrombocytopenia syndrome (SFTS) in Japan: a pathognomonic histological feature and unique complication of SFTS. Pathol Int (2014) 0.94
Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64. J Virol (2010) 0.93
Establishment of an HIV cell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene. J Virol Methods (2003) 0.93
Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection. Biochem Biophys Res Commun (2011) 0.93
Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir. Antimicrob Agents Chemother (2003) 0.93
Cochaperone activity of human butyrate-induced transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent pathway. J Virol (2009) 0.92
Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein. Clin Diagn Lab Immunol (2003) 0.92
Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses. J Virol (2005) 0.91
Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. Biochem Biophys Res Commun (2005) 0.91
Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever. Clin Vaccine Immunol (2007) 0.91
Antigen-capture ELISA for the detection of Rift Valley fever virus nucleoprotein using new monoclonal antibodies. J Virol Methods (2012) 0.91
A seroepidemiologic study of Reston ebolavirus in swine in the Philippines. BMC Vet Res (2012) 0.90
Establishment of a human preadipose cell line, HPB-AML-I: refractory to PPARgamma-mediated adipogenic stimulation. J Cell Physiol (2003) 0.90
Canine distemper virus associated with a lethal outbreak in monkeys can readily adapt to use human receptors. J Virol (2013) 0.90
Development and Applications of VSV Vectors Based on Cell Tropism. Front Microbiol (2012) 0.90